IMMUNOPOIESIS-MODULATING PROPERTIES OF BIOFLAVONOIDES ORIGINAL COMPLEX «EPIGENORM ANTIVIR»

封面

如何引用文章

全文:

详细

Food plants bioflavonoids have chemoprotective and immunomodulatory properties, including the ability to affect the earliest stages of immunopoiesis, therefore the development of complex adjuvant therapeutic compositions on their basis is of undoubted relevance. The purpose of this study was to identify the immunopoiesis modulating and chemoprotective properties of the natural food polyphenols original complex “Epigenorm antivir”. As a result of the study, it was found that “Epigenorm antivir” increases the functional activity of bone marrow stem cells – the early common precursors of hematopoiesis, and also it has chemoprotective properties, the ability to increasing of the hematopoietic stem cell functional activity under the immunosuppression conditions.

作者简介

I. Goldina

Federal state budgetary scientific institution “Scientific research institute of fundamental and clinical immunology”

编辑信件的主要联系方式.
Email: iigoldina@mail.ru

researcher of the Neuroimmunology laboratory,

Novosibirsk

俄罗斯联邦

E. Markova

Federal state budgetary scientific institution “Scientific research institute of fundamental and clinical immunology”;
Federal State Budgetary Educational Institution of Higher Education “Novosibirsk State Pedagogical University»

Email: fake@neicon.ru

Head of the Neuroimmunology laboratory, chief researcher;

professor,

Novosibirsk

俄罗斯联邦

I. Orlovskaya

Federal state budgetary scientific institution “Scientific research institute of fundamental and clinical immunology”

Email: fake@neicon.ru

MD, Professor, head of the Stem cell immunobiology laboratory,

Novosibirsk

俄罗斯联邦

L. Toporkova

Federal state budgetary scientific institution “Scientific research institute of fundamental and clinical immunology”

Email: fake@neicon.ru

PhD, senior scientifi c researcher of the Stem cell immunobiology laboratory,

Novosibirsk

俄罗斯联邦

参考

  1. Ohm J. E., Carbone D. P. VEGF as a mediator of tumor-associated immunodeficiency. Immunol. Res. 2001, 23(2–3), 263–72.
  2. Weissman I. L. Stem cells: Units of development, units of regeneration, and units in evolution. Cell 2000, 100, 157–168.
  3. Wei Q., Frenette P. S. Niches for hematopoietic stem cells and their progeny. Immunity 2018, 48, 632–648.
  4. Attari F., Zahmatkesh M., Aligholi H., Mehr S. E., Sharifzadeh M., Gorji A., Mokhtari T., Khaksarian M., Hassanzadeh G. Curcumin as a double-edged sword for stem cells: dose, time and cell type-specifi c responses to curcumin. Daru 2015, 23, 33. doi: 10.1186/s40199- 015-0115-8.
  5. Гайдуль К. В., Гольдина И. А., Сафронова И. В. Исследование морфометрических параметров органов иммунной системы под действием нутрицевтика эпигеном-направленного действия на фоне экспериментальной гемодепрессии. Журнал научных статей «Здоровье и образование в XXI веке» 2018, 20, (10), 10–13. dx.doi.org/10.26787/nydha2226-7425-2018-20-10-10-13.
  6. Гольдина И. А., Гайдуль К. В. Биологическая активность и терапевтические свойства Curcuma Longa L. (Обзор литературы) Вестник Новосибирского государственного университета. Серия: Биология, клиническая медицина 2015, 13(1), 106–114.
  7. Гольдина И. А., Маркова Е. В., Гольдин Б. Г., Княжева М. А., Гайдуль К. В. Протекторные свойства экстракта куркумы при этанолиндуцированных нарушениях поведения. Саратовский научномедицинский журнал 2017, 13(1), 131–135.
  8. Любимов Г. Ю., Гольдина И. А., Гайдуль К. В., Козлов В. А. Противоопухолевые свойства экстракта корневищ Curcuma Longa L. в глицерине на модели роста экспериментальной меланомы мышей В16. Сибирский научный медицинский журнал 2016, 36(4), 56–60.
  9. Piao L., Mukherjee S., Chang Q., Xie X., Li H., Castellanos M. R., Banerjee P., Iqbal H., Ivancic R., Wang X., Teknos T. N., Pan Q. TriCurin, a novel formulation of curcumin, epicatechin gallate and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma. Oncotarget. 2016, 8(36), 60025–60035. doi: 10.18632/oncotarget.10620. doi: 10.18632/oncotarget.10620.
  10. Душкин А. В., Гайдуль К. В., Гольдина И. А., Гуськов С. А., Евсеенко В. И., Ляхов Н. З., Козлов В. А. Антимикробная активность механохимически синтезированных композитов антибиотиков и наноструктурированного диоксида кремния. Доклады АН 2012, 443(1), 120–122.
  11. Lin S. Y., Kang L., Wang C. Z., Huang H. H., Cheng T. L., Huang H. T., Chen C. H. (–)-Epigallocatechin-3-Gallate (EGCG) Enhances Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells. Molecules (Basel, Switzerland) 2018, 23(12), 3221. doi: 10.3390/molecules23123221.
  12. Drapeau C., Benson K. F., Jensen G. S. Rapid and selective mobilization of specific stem cell types after consumption of a polyphenol-rich extract from sea buckthorn berries (Hippophae) in healthy human subjects. Clinical interventions in aging 2019 14, 253–263. doi: 10.2147/CIA.S186893.
  13. Chen X., Zhi X., Yin Z., Li X., Qin L., Qiu Z., Su J. 18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL–Mediated RANK-TRAF6 Interactions and NF-κB and MAPK Signaling Pathways. Frontiers in pharmacology 2018, 9, 647. doi: 10.3389/fphar.2018.00647.
  14. Vishvakarma N. K., Kumar A., Kant S, Bharti A. C., Singh S. M. Myelopotentiating effect of curcumin in tumor-bearing host: role of bone marrow resident macrophages. Toxicol. Appl. Pharmacol. 2012, 263(1), 111–21. doi: 10.1016/j.taap.2012.06.004.
  15. Fu Z., Chen X., Guan S., Yan Y., Lin H., Hua Z.-C. Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway. Oncotarget 2015, 6(23), 19469–19482. doi: 10.18632/oncotarget.3625.
  16. Chen X., Wang J., Fu Z., Zhu B., Wang J., Guan S., Hua Z. Curcumin activates DNA repair pathway in bone marrow to improve carboplatin-induced myelosuppression. Scientifi c Reports 2017, 7, 17724. doi: 10.1038/s41598-017-16436-9.
  17. Mohammadi S., Ghaffari S. H., Shaiegan M., Zarif M. N., Nikbakht M., Akbari Birgani S., Alimoghadam K., Ghavamzadeh A. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/beta-catenin pathways in AML cells. Life Sci. 2016b, 152, 190–198.

版权所有 © Goldina I.A., Markova E.V., Orlovskaya I.A., Toporkova L.B., 2019

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可
##common.cookie##